Characterization of Five Natural Anthraquinone Compounds as Potent Inhibitors against CYP1B1: Implications for Cancer

Zujia Chen1, Zhixiang Xu1, Xiaodong Chen1

  • 1Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Liaoning Dalian, China.

Current Drug Metabolism
|January 22, 2025
PubMed
Abstract

Insights

Five natural anthraquinones from Cassiae semen, including aloe-emodin and chrysophanol, effectively inhibit human cytochrome P450 1B1 (CYP1B1) activity. This study elucidates their structure-activity relationship, offering insights into potential antitumor properties.

Area of Science:

  • Pharmacology and Biochemistry
  • Natural Product Chemistry
  • Enzyme Inhibition Studies

Background:

  • Human cytochrome P450 1B1 (CYP1B1) is implicated in tumor development and resistance.
  • Anthraquinones are known to inhibit CYP1B1, but mechanisms are often unclear.
  • Cassiae semen contains bioactive anthraquinones with diverse pharmacological effects.

Purpose of the Study:

  • To investigate the inhibitory effects of five key anthraquinones from Cassiae semen on CYP1B1 activity.
  • To analyze the structure-activity relationships governing CYP1B1 inhibition by these compounds.
  • To explore the potential antitumor mechanisms of these natural compounds.

Main Methods:

  • Enzyme inhibition assays using 7-ethoxyresorufin O-deethylation (EROD) as a substrate for CYP1B1.
  • Determination of IC50 values for aloe-emodin, chrysophanol, obtusifolin, aurantio-obtusin, and rhein.
  • Molecular docking simulations to elucidate binding interactions and structure-activity relationships.

Main Results:

  • Aloe-emodin and chrysophanol demonstrated potent CYP1B1 inhibition (IC50: 0.28 μM and 0.34 μM, respectively).
  • Obtusifolin and aurantio-obtusin showed moderate inhibition (IC50: 0.77 μM and 9.11 μM, respectively).
  • Inhibition was non-competitive, with activity influenced by hydroxyl and methoxy group substitutions; rhein exhibited weakest inhibition.

Conclusions:

  • Five natural anthraquinones from Cassiae semen exhibit significant inhibitory effects on CYP1B1.
  • Structure-activity relationship analysis reveals key determinants for CYP1B1 inhibition.
  • Findings support the investigation of these anthraquinones for potential anticancer applications.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
147
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
201